Commercial interest in human embryonic stem cells remains strong as the Wisconsin Alumni Research Foundation announced the signing of a licensing agreement with VistaGen Therapeutics, a California biotechnology firm. The company will use human embryonic stem cell technology, based on patented science developed by researcher...
UW-Madison cellular biology professor and stem cell researcher James Thomson has received the prestigious Massry Prize for 2008, which recognizes Thomson for his groundbreaking 1998 discovery of human embryonic stem (ES) cells and his subsequent work in developing induced pluripotent stem (iPS) cells. The Massry...
Cellular Dynamics International has appointed key commercial, operations, and financial executives. The Madison-based stem cell company, which recently raised $18 million in capital, says it will bring on Chris Kendrick-Parker as chief commercial officer, and former Roche NimbleGen execs Emile Nuwaysir as COO and David...
Richard S. Schifreen, a former biotech executive at Mirus Bio and Promega Corp., has been named president and CEO of Platypus Technologies, a Madison-based developer of nanotechnology-based products for the biotechnology and sensor industries. Schifreen was brought on board Dec. 10 and succeeds former CEO...
Madison, Wis. - TomoTherapy has announced that co-founder Paul J. Reckwerdt will retire as president and relinquish his board directorship effective Dec. 31, 2008. Reckwerdt plans to pursue entrepreneurial opportunities and will serve as a strategic advisor to Compact Particle Acceleration Corporation (CPAC), which is developing...
Madison, Wis. - The Greater Madison Area Directory of High-Tech Companies is compiled and published annually by Madison Gas and Electric Co., a corporate member of Accelerate Madison. Final deadline for life science and other technology-related companies to submit entries for the 2009 directory is Friday,...
Just how worthwhile was the discovery of how to grow human embryonic stem (ES) cells? While there have been no therapies yet to come from the discovery, there is little doubt that it could transform the practice of medicine and drug development, and the Age...
Madison, Wis. - Quintessence Biosciences announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for the first of the Company's EVade Ribonuclease drug candidates, called QBI-139. The company will begin a Phase I trial of QBI-139 in...
Back from his trip to BIO-Europe, columnist Michael Rosen caught a glimpse of what a tough year 2009 is looking like for biotechnology on a global scale. Nevertheless, the global need for better medicines and treatment of diseases never seems to lapse into a recession,...
A Chicago man was among those killed in widespread terrorist attacks in Mumbai, family members and the head of his Wisconsin-based company said Sunday. Sandeep "Sam" Jeswani, 43, of 1400 block of West Berwyn Avenue in the Andersonville neighborhood, died during the attacks, according to his...